RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 3, 2010, Pages 276-286

  Klingel, Reinhard ^a,b   Fassbender, Cordula ^a   Heibges, Andreas ^a   Koch, Frank ^c   Nasemann, Joachim ^d   Engelmann, Katrin ^e   Carl, Thomas ^d   Meinke, Michael ^a   Erdtracht, Bernard ^f  

^a Apheresis Research Institute   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e Clinic for Ophthalmology and Vitroretinal Surgery   (Germany)

^f Hospital Chemnitz   (Germany)

Author keywords

Apheresis; Dry age related macular degeneration; Microcirculatory disorder; Quality management; Registry; Rheopheresis

Indexed keywords

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLEEDING; BRADYCARDIA; CHILL; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE REGISTRY; DIZZINESS; EDEMA; FEVER; HEADACHE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEMATOMA; HUMAN; HYPERTENSION; HYPOTENSION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MICROANGIOPATHY; NAUSEA AND VOMITING; OUTPATIENT DEPARTMENT; PARESTHESIA; PATIENT SAFETY; PLASMAPHERESIS; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RHEOPHERESIS; SYNCOPE; TACHYCARDIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL ACUITY; VISUAL IMPAIRMENT; APHERESIS; FEMALE; FOLLOW UP; MACULAR DEGENERATION; MALE; PATHOPHYSIOLOGY; REGISTER; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD COMPONENT REMOVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; MACULAR DEGENERATION; MALE; REGISTRIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77952939041     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00807.x     Document Type: Article

References (27)

1. U.S. Renal Data System. USRDS 2008 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008 Accessed 17 February 2009.] Available from URL: http://www.usrds.org
2. Stegmayr B, Ptak J, Wiström B et al. World apheresis registry 2003-2007 data. Transfus Apher Sci 2008 39 : 247 254.
3. Norda R, Stegmayr BG, The Swedish Apheresis Group. Therapeutic Apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 2003 29 : 159 166.
4. Korach J-M, Guillevin L, Peptitpas D, Berger P, Chillet P, The French registry study group. Apheresis registry in France: indications, techniques and complications. Ther Apher 2000 4 : 200 210.
5. Rock G, Clark B, Sutton D, members of the CAG and CAAN. The Canadian apheresis registry. Transfus Apher Sci 2003 29 : 167 177.
6. Malchesky P, Koo AP, Roberson GA, Hadsell AT, Rybicki LA. Apheresis technologies and clinical applications: the 2005 international apheresis registry. Ther Apher Dial 2007 11 : 341 362.
7. Klingel R, Fassbender C, Fassbender T, Erdtracht B, Berrouschot J. Rheopheresis: rheologic, functional and structural aspects. Ther Apher 2000 4 : 348 357.
8. Kirschkamp T, Schmid-Schönbein H, Weinberger A, Smeets R. Effects of fibrinogen and alpha-2-Macorglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates. Ther Apher Dial 2008 12 : 360 367.
9. Pulido JS, Sanders D, Klingel R. Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action. Can J Ophthalmol 2005 40 : 332 340. (Pubitemid 40942260)
10. Klingel R, Erdtracht B, Gauss V, Piazolo A, Mausfeld-Lafdhiya P, Diehm C. Rheopheresis in patients with critical limb ischemia- results of an open label prospective pilot trial. Ther Apher Dial 2005 9 : 473 481.
11. Klingel R, Mumme Ch, Fassbender T et al. Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial. Ther Apher Dial 2003 7 : 444 455.
12. Klingel R, Fassbender C, Faßbender T, Göhlen B. Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine. Transfus Apher Sci 2003 29 : 71 84.
13. Moesges R, Köberlein J, Heibges A et al., for the RHEO-ISHL Study Group. Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 2008 266 : 943 953.
14. Moesges R, Köberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W for the RHEO-ISHL Study Group. Quality of life in patients with idiopathic sudden hearing loss (ISHL):Comparison of different therapies using the SF-36 questionnaire. Otol Neurotol 2008 29 : 769 775.
15. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Arch Ophthalmol 2004 122 : 564 572.
16. Klaver CCW, Assink JJM, van Leeuwen R et al. Incidence and progression rates of age-related maculopathy: The Rotterdam study. Invest Ophthalmol Vis Sci 2001 42 : 2237 2241.
17. Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in age-related macular degeneration. Retina 2007 27 : 269 275.
18. Brunner R, Widder RA, Walter P et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration, a randomized trial. Retina 2000 20 : 483 491.
19. Widder RA, Farvili E, Reis RG et al. The treatment of age-related macular degeneration (ARMD) with extracorporeal treatment procedures, a follow-up of four years. Invest Ophthalmol Vis Sci 2002 43 E-abstract 2906.
20. Swartz M, Rabetoy G. Treatment of non-exudative age-related macular degeneration using membrane differential filtration apheresis (abstract). Invest Ophthalmol Vis Sci 1999 40 : 319.
21. Pulido JS, Winters JL, Boyer D. Preliminary analysis of the final multicenter investigation of rheopheresis for age-related macular degeneration (AMD) trial (MIRA-1) results. Trans Am Opthalmol Soc 2006 104 : 221 231.
22. Koss MJ, Kurz P, Tsobanelis T. Prospective, randomized, controlled clinical study evaluating the efficacy of rheopheresis for dry age-related macular degeneration - Dry AMD treatment with Rheopheresis Trial - ART. Graefes Arch Clin Exp Ophthalmol 2009 247 : 1297 1306.
23. Gass JD, Agarwl A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen. An early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003 23 : 741 751.
24. Norda R, Stegmayr BG, The Swedish Apheresis Group. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apher Sci 2001 25 : 33 41.
25. Bosch T, Gahr S, Belschner U et al. Direct adsorption of low-density lipoprotein by DALI-LDL-Apheresis: results of a prospective long-term multicenter follow-up covering 12291 sessions. Ther Apher Dial 2006 10 : 3 : 210 218.
26. Berrouschot J, Barthel H, Köster J et al. Extracorporeal rheopheresis in the treatment of acute ischemic stroke. Stroke 1999 30 : 787 792.
27. Wild C, Mathis B, Garthlehner G. Rheopheresis for age-related macular degeneration. Ophthalmologe 2009 106 : 127 132.